Para IV Winners and Losers - November 2024

The report highlights all important opportunities for the generic companies based on the latest patent litigation updates. The analyses provides an insight into each product opportunity for generic companies in terms of 

1. likely timeline of the first generic launch in US
2. potential competition on the first day of launch and
3. companies likely to benefit in case of a probable launch under low competition

The report is derived from our Para IV Insights database that covers all Para IV litigations from 2012 onwards.